The 305 nm photofragmentation dynamics of nitrosobenzene was measured using velocity-mapped ion imaging with polarized 1+1' resonance-enhanced multiphoton ionization probing of the NO (X, v"=0) fragment. The product recoil energy and angular distributions of selected rotational states of NO (X (2)Pi(1/2,3/2)) products have been measured. The recoil anisotropy of the NO photofragment is very small with beta(0)(2)(20)=0.03. The v-j vector correlation of NO shows a preference for v//j with an average value of beta(0)(0)(22)=+0.15 over the transitions studied. A mechanism involving dissociation from the ground state is used to explain the unusual propellerlike trajectory of the nascent NO.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1063/1.3319747 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vector-Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity-Clamped Gene Electrotransfer.
Adv Sci (Weinh)
January 2025
Translational Neuroscience Facility, Department of Physiology, School of Biomedical Sciences, Graduate School of Biomedical Engineering, Tyree Institute for Health Engineering (IHealthE), UNSW, Sydney, NSW, 2052, Australia.
Viral vector and lipid nanoparticle based gene delivery have limitations around spatiotemporal control, transgene packaging size, and vector immune reactivity, compromising translation of nucleic acid (NA) therapeutics. In the emerging field of DNA and particularly RNA-based gene therapies, vector-free delivery platforms are identified as a key unmet need. Here, this work addresses these challenges through gene electrotransfer (GET) of "naked" polyanionic DNA/mRNA using a single needle form-factor which supports "electro-lens" based compression of the local electric field, and local control of tissue conductivity, enabling single capacitive discharge minimal charge gene delivery.
View Article and Find Full Text PDFReversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.
Mol Ther
December 2024
Center of Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain. Electronic address:
The highly prevalent metabolic dysfunction-associated steatohepatitis (MASH) is associated with liver steatosis, inflammation, and hepatocyte injury, which can lead to fibrosis and may progress to hepatocellular carcinoma and death. New treatment modalities such as gene therapy may be transformative for MASH patients. Here, we describe that one-time intramuscular administration of adeno-associated viral vectors of serotype 1 (AAV1) encoding native fibroblast growth factor 21 (FGF21), a key metabolic regulator, resulted in sustained increased circulating levels of the factor, which mediated long-term (>1 year) MASH and hepatic fibrosis reversion and halted development of liver tumors in obese male and female mouse models.
View Article and Find Full Text PDFA multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study.
Vaccine
December 2024
Bavarian Nordic, Bavarian Nordic Switzerland AG, Zug, Switzerland.
Article Synopsis
- - The study evaluated the efficacy of the MVA-BN-RSV vaccine, designed for older adults (≥60 years), against respiratory disease caused by RSV during the 2022-2023 season, involving 18,348 participants who received either the vaccine or a placebo.
- - Vaccine efficacy was reported as 42.9% against RSV-associated lower respiratory tract disease (LRTD) with 3 symptoms and 59.0% against LRTD with 2 symptoms; however, the primary endpoint was not met due to the lower confidence interval being below a predetermined success criterion.
- - The vaccine demonstrated mild to moderate side effects, showed promise by confirming immunogenicity (increased antibody responses), but provided
Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness.
Mol Ther Methods Clin Dev
September 2024
Genethon, 91000 Evry, France.
Adeno-associated virus (AAV) is the most widely used vector for gene transfer. A major limitation of capsid engineering is the incomplete understanding of the consequences of multiple amino acid variations on AAV capsid stability resulting in high frequency of non-viable capsids. In this context, the study of natural AAV variants can provide valuable insights into capsid regions that exhibit greater tolerance to mutations.
View Article and Find Full Text PDFPreclinical studies of gene replacement therapy for CDKL5 deficiency disorder.
Mol Ther
October 2024
PTC Therapeutics, Inc, 500 Warren Corporate Center Drive, Warren, NJ 07059, USA. Electronic address:
Article Synopsis
- - CDD is a rare neurodevelopmental disorder linked to mutations in the CDKL5 gene, leading to symptoms like epilepsy, muscle weakness, and developmental delays.
- - Researchers created a gene therapy vector, AAV9.Syn.hCDKL5, to deliver the CDKL5 gene to the brain, using a specific promoter to enhance gene expression.
- - Studies in mice showed that injecting the vector directly into the cerebrospinal fluid improved distribution and resulted in biological activity, with successful functional improvements observed at higher doses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!